期刊文献+

Current status of severe acute respiratory syndrome in China 被引量:14

Current status of severe acute respiratory syndrome in China
下载PDF
导出
摘要 Severe acute respiratory syndrome (SARS), also called infectious atypical pneumonia, is an emerging infectious disease caused by a novel variant of coronavirus (SARS associated coronavirus, SARS-CoV). It is mainly characterized by pulmonary infection with a high infectivity and fatality.SARS is swept across almost all the continents of the globe, and has currently involved 33 countries and regions, including the China's Mainland, Hong Kong, Taiwan, North America and Europe. On June 30, 2003, an acumulative total reached 8450 cases with 810 deaths. SARS epidemic was very rampant in March, April and May 2003 in the mainland of China and Hong Kong. Chinese scientists and healthcare workers cooperated closely with other scientists from all over the world to fight the disease. On April 16, 2003, World Health Organization (WHO) formally declared that SARSCoV was an etiological agent of SARS. Currently, there is no specific and effective therapy and prevention method for SARS. The main treatments include corticosteroid therapy,antiviralagents, anti-infection, mechanical ventilation and isolation. This disease can be prevented and controlled, and it is also curable. Under the endeavor of the Chinese Government, medical staffs and other related professionals,SARS has been under control in China, and Chinese scientists have also made a great contribution to SARS research.Otherstudies in developing new detection assays and therapies, and discovering new drugs and vaccines are in progress. In this paper, we briefly review the current status of SARS in China. Severe acute respiratory syndrome (SARS), also called infectious atypical pneumonia, is an emerging infectious disease caused by a novel variant of coronavirus (SARS-associated coronavirus, SARS-CoV). It is mainly characterized by pulmonary infection with a high infectivity and fatality. SARS is swept across almost all the continents of the globe, and has currently involved 33 countries and regions, including the China's Mainland, Hong Kong, Taiwan, North America and Europe. On June 30, 2003, an acumulative total reached 8450 cases with 810 deaths. SARS epidemic was very rampant in March, April and May 2003 in the mainland of China and Hong Kong. Chinese scientists and healthcare workers cooperated closely with other scientists from all over the world to fight the disease. On April 16, 2003, World Health Organization (WHO) formally declared that SARS-CoV was an etiological agent of SARS. Currently, there is no specific and effective therapy and prevention method for SARS. The main treatments include corticosteroid therapy, anti-viral agents, anti-infection, mechanical ventilation and isolation. This disease can be prevented and controlled, and it is also curable. Under the endeavor of the Chinese Government, medical staffs and other related professionals, SARS has been under control in China, and Chinese scientists have also made a great contribution to SARS research. Other studies in developing new detection assays and therapies, and discovering new drugs and vaccines are in progress. In this paper, we briefly review the current status of SARS in China.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2003年第8期1635-1645,共11页 世界胃肠病学杂志(英文版)
  • 相关文献

参考文献14

二级参考文献86

  • 1Pelletier G, Déry P, Abed Y, et al. Respiratory tract reinfections by the New Human Metapneumovirus in an immunocompromised child[J]. Emerg Infect Dis, 2002, 8-9.
  • 2Ksiazek T G, Erdman D, Goldsmith C S, et al. A novel coronavirus associated with severe acute respiratory syndrome [J]. N Engl J Med,2003, Apr 30.
  • 3Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome[J]. N Engl J Med,2003,Apr 10.
  • 4Rota P A, Oberste M S, Monroe S S, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome [J]. Science, 2003, May 1.
  • 5Marra M A, Jones S J, Astell C R, et al. The genome sequence of the SARS - associated coronavirus [J]. Science, 2003, May 1.
  • 6Booth C M, Matukas L M, Tomlinson G A, et al. Clinical features and short - term outcomes of 144 patients with SARS in the greater toronto area [J]. JAMA, 2003, May 6.
  • 7Maunder R, Hunter J, Vincent L, et al. The immediate psychological and occupational impact of the 2003 SARS outbreak in a teaching hospital[J]. CMAJ,2003, 168(10):1245 - 1251.
  • 8Lapinsky S E, Hawryluck L. ICU management of severe acute respiratory syndrome [J]. Intensive Care Med, 2003, May 9.
  • 9Wu E B, Sung J J. Haemorrhagic -fever -like changes and normal chest radiograph in a doctor with SARS[J]. Lancet, 2003, 361(9368):1520 - 1521.
  • 10Wong K T, Antonio G E, Hui D S, et al. Thin -section CT of severe acute respiratory syndrome: evaluation of 74 patients exposed to or with the disease[J]. Radiology, 2003, May 8.

共引文献348

同被引文献57

  • 1杜湘珂,郁万江,王思伦,朱奇志,洪楠.SARS的临床与影像分析[J].中华放射学杂志,2003,37(9):780-783. 被引量:14
  • 2荣宝刚,陈玮伦,丁元萍,丁寿玲,许安廷,陈瑛,王天铎.闭合式乳突根治并鼓室成形术的临床研究[J].中华耳鼻咽喉头颈外科杂志,2005,40(6):449-451. 被引量:23
  • 3聂青和,张开瑞.新的致病性弧菌与感染性腹泻[J].中国实用内科杂志,1995,15(4):251-252. 被引量:4
  • 4聂青和.艾滋病与感染性腹泻的研究现状[J].国外医学(病毒学分册),1996,3(1):24-26. 被引量:6
  • 5孙正良,刘阳云,冯秀荣,江文,李正贤.完壁式鼓室成形术治疗胆脂瘤型中耳炎的疗效观察[J].中华耳科学杂志,2007,5(2):145-147. 被引量:13
  • 6He Y,Zhou Y,Liu S,Kou Z,Li W,Farzan M,Jiang S.Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing sub-unit vaccine[].Biochemical and Biophysical Research Communications.2004
  • 7Zeng F,Chow KY,Hon CC,Law KM,Yip CW,Chan KH,Peiris JS,Leung FC.Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments[].Biochemical and Biophysical Research Communications.2004
  • 8Wong SK,Li W,Moore MJ,Choe H,Farzan M.A 193-amino-acid fragment of the SARS coronavirus S protein efficiently binds angiotensin- converting enzyme 2[].Journal of Biological Chemistry.2004
  • 9Yang ZY,Kong WP,Huang Y,Roberts A,Murphy BR,Subbarao K,Nabel GJ.A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice[].Nature.2004
  • 10Ho Y,Lin PH,Liu CY,Lee SP,Chao YC.Assembly of human severe acute respiratory syndrome coronavirus-like particles[].Biochemistry and Biophysics.2004

引证文献14

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部